Who owns Sarepta Therapeutics note 1.500% 11/1?
- CUSIP Number: 803607ab6
Tip: Access positions for across all investors
Analyze quarterly positions in Sarepta Therapeutics note 1.500% 11/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sarepta Therapeutics note 1.500% 11/1 stock
Who bought or sold Sarepta Therapeutics note 1.500% 11/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DLD Asset Management | 15M | $21M | 41% | Dec 2023 |
|
| Point72 Asset Management | 14M | $25M | 0% | Mar 2024 |
|
| D. E. Shaw & Co | 11M | $20M | 0% | Mar 2024 |
|
| CSS | 8.2M | $15M | 0% | Mar 2024 |
|
| Capstone Investment Advisors | 5.1M | $9.1M | 0% | Mar 2024 |
|
| Boothbay Fund Management | 3.5M | $6.3M | -10% | Mar 2024 |
|
| FMR | 1.4M | $2.6M | -3% | Mar 2024 |
|
| Warberg Asset Management | 1.0M | $1.8M | 83% | Mar 2024 |
|
| Palisade Capital Management | 1.0M | $1.8M | 0% | Mar 2024 |
|
| Wolverine Asset Management | 156k | $279k | 0% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 68k | $122k | 0% | Mar 2024 |
|
| Morgan Stanley | 52k | $93k | 2500% | Mar 2024 |
|
| Fox Hill Wealth Management | 24k | $43k | 4% | Mar 2024 |
|
| Virtus Investment Advisers | 4.0k | $7.1k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 2.0k | $3.5k | 100% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 2.0k | $3.6k | 0% | Mar 2024 |
|
| Citigroup | 1.0k | $1.8k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 1.0k | $1.8k | 0% | Mar 2024 |
|
| Bank of America Corporation | 1.0k | $1.8k | -100% | Mar 2024 |
|
Who sold out of Sarepta Therapeutics note 1.500% 11/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Worth Venture Partners | Dec 2023 | 2.8M | $4.0M |
| Leucadia National Corporation | Dec 2023 | 140k | $196k |
| American Century Companies | Sep 2023 | 75k | $133k |
| Royal Bank of Canada | Dec 2023 | 2.0k | $3.0k |